NIDCD Definitive Phase III Clinical Trial Planning Grant (R34)

The summary for the NIDCD Definitive Phase III Clinical Trial Planning Grant (R34) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NIDCD Definitive Phase III Clinical Trial Planning Grant (R34): Purpose. The goal of this FOA is to provide support to complete the development of a comprehensive research protocol for large-scale, multicenter Phase III Definitive Clinical Trials (DCT). The planning grant is designed to permit early peer review of the proposed clinical trial in terms of its rationale, general design, organizational structure and implementation plan. The planning grant is used to support the development of a detailed Manual of Procedures (MOP) which is required for submission when applying for a Phase III Definitive Clinical Trial (PAR-08-205). The planning grant will provide support to establish the research team, develop tools for data management and oversight of the research, define recruitment strategies, and develop and finalize the MOP. The Planning Grant is NOT intended to support small Phase I/II Preliminary Clinical Trials. Applications for Phase I/II Preliminary Clinical Trials should use the NIDCD Phase I/II Preliminary Clinical Trials in Communication Disorders (PAR-08-204). Mechanism of Support. This FOA will utilize the R34 funding mechanism. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.

Federal Grant Title:	NIDCD Definitive Phase III Clinical Trial Planning Grant (R34)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-09-142
Type of Funding:	Grant
CFDA Numbers:	93.173
CFDA Descriptions:	Research Related to Deafness and Communication Disorders
Current Application Deadline:	May 07, 2012
Original Application Deadline:	May 07, 2012
Posted Date:	Apr 03, 2009
Creation Date:	Apr 03, 2009
Archive Date:	Jun 07, 2012
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Medical Rehabilitation Research Resource (P50 Clinical Trial Optional); • Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Tr...; • BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Centr...; • BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional); • NIDCD Patient-Oriented Research Grant (R21); • Cell Lineage and Developmental Studies in Hearing and Balance; • Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...